LncTarD 2.0: an updated comprehensive database for experimentally-supported functional lncRNA–target regulations in human diseases
Authors:
Open Access
- 2 November 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 51 (D1) , D199-D207
Abstract
An updated LncTarD 2.0 database provides a comprehensive resource on key lncRNA–target regulations, their influenced functions and lncRNA-mediated regulatory mechanisms in human diseases. LncTarD 2.0 is freely available at (http://bio-bigdata.hrbmu.edu.cn/LncTarD or https://lnctard.bio-database.com/). LncTarD 2.0 was updated with several new features, including (i) an increased number of disease-associated lncRNA entries, where the current release provides 8360 key lncRNA–target regulations, with 419 disease subtypes and 1355 lncRNAs; (ii) predicted 3312 out of 8360 lncRNA–target regulations as potential diagnostic or therapeutic biomarkers in circulating tumor cells (CTCs); (iii) addition of 536 new, experimentally supported lncRNA–target regulations that modulate properties of cancer stem cells; (iv) addition of an experimentally supported clinical application section of 2894 lncRNA–target regulations for potential clinical application. Importantly, LncTarD 2.0 provides RNA-seq/microarray and single-cell web tools for customizable analysis and visualization of lncRNA–target regulations in diseases. RNA-seq/microarray web tool was used to mining lncRNA–target regulations in both disease tissue samples and CTCs blood samples. The single-cell web tools provide single-cell lncRNA–target annotation from the perspectives of pan-cancer analysis and cancer-specific analysis at the single-cell level. LncTarD 2.0 will be a useful resource and mining tool for the investigation of the functions and mechanisms of lncRNA deregulation in human disease.Keywords
Funding Information
- University Nursing Program for Young Scholar with Creative Talents in Heilongjiang Province (UNPYSCT-2020174)
- Excellent Youth Project of Provincial scientific research Institute (CZKYF2022-1-C006)
- Hei Long Jiang Postdoctoral Special Foundation (LBH-TZ1018)
This publication has 49 references indexed in Scilit:
- Circulating lncRNA XLOC_009167 serves as a diagnostic biomarker to predict lung cancerClinica Chimica Acta, 2018
- LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expressionMolecular Cancer, 2018
- Vimentin Is Required for Lung Adenocarcinoma Metastasis via Heterotypic Tumor Cell–Cancer-Associated Fibroblast Interactions during Collective InvasionClinical Cancer Research, 2018
- Long noncoding RNA LINC00313 modulates papillary thyroid cancer tumorigenesis via sponging miR-4429Neoplasma, 2018
- Overexpression of LncRNA AFAP1-AS1 predicts poor prognosis and promotes cells proliferation and invasion in gallbladder cancerBiomedicine & Pharmacotherapy, 2016
- The up-regulation of long non-coding RNA AFAP1-AS1 is associated with the poor prognosis of NSCLC patientsBiomedicine & Pharmacotherapy, 2015
- limma powers differential expression analyses for RNA-sequencing and microarray studiesNucleic Acids Research, 2015
- Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledgeContemporary Oncology, 2015
- Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2Genome Biology, 2014
- NCBI GEO: archive for functional genomics data sets—updateNucleic Acids Research, 2012